The General Practice and Residential Aged Care Facility Concordance of Medication (GRACEMED) study.

electronic health records medication discrepancies medications nursing homes primary health care

Journal

International journal of medical informatics
ISSN: 1872-8243
Titre abrégé: Int J Med Inform
Pays: Ireland
ID NLM: 9711057

Informations de publication

Date de publication:
11 2020
Historique:
received: 15 01 2020
revised: 25 08 2020
accepted: 25 08 2020
pubmed: 10 9 2020
medline: 22 12 2020
entrez: 9 9 2020
Statut: ppublish

Résumé

The lack of interoperable IT systems between residential aged care facilities (RACF) and general practitioners (GP) in primary care settings in Australia introduces the potential for medication discrepancies and other medication errors. The aim of the GRACEMED study is to determine the extent and potential severity of medication discrepancies between general practice and RACFs, and identify factors associated with medication discrepancies. A cross sectional study of medication discrepancies between RACF medication orders and GP medication lists was conducted in the Sydney North Health Network, Australia. A random sample of RACF residents was included from practice lists provided by the general practices. RACF medication orders and GP medication lists for the included residents were compared, and medication discrepancies between the two sources were identified and characterised in terms of discrepancy type, potential for harm and associated factors. 31 GPs and 203 residents were included in the study. A total of 1777 discrepancies were identified giving an overall discrepancy rate of 72.6 discrepancies for every 100 medications. Omissions were the most common discrepancy type (35.2%,) followed by dose discrepancies (34.4%) and additions (30.4%). 48.5% of residents had a discrepancy with the potential to result in moderate harm and 9.8% had a discrepancy with the potential for severe harm. Number of medications prescribed was the only factor associated with medication discrepancies. Increased use of systems that allow information sharing and improved interoperability of clinical information is urgently needed to address medication safety issues experienced by RACF residents.

Sections du résumé

BACKGROUND
The lack of interoperable IT systems between residential aged care facilities (RACF) and general practitioners (GP) in primary care settings in Australia introduces the potential for medication discrepancies and other medication errors. The aim of the GRACEMED study is to determine the extent and potential severity of medication discrepancies between general practice and RACFs, and identify factors associated with medication discrepancies.
METHODS
A cross sectional study of medication discrepancies between RACF medication orders and GP medication lists was conducted in the Sydney North Health Network, Australia. A random sample of RACF residents was included from practice lists provided by the general practices. RACF medication orders and GP medication lists for the included residents were compared, and medication discrepancies between the two sources were identified and characterised in terms of discrepancy type, potential for harm and associated factors.
RESULTS
31 GPs and 203 residents were included in the study. A total of 1777 discrepancies were identified giving an overall discrepancy rate of 72.6 discrepancies for every 100 medications. Omissions were the most common discrepancy type (35.2%,) followed by dose discrepancies (34.4%) and additions (30.4%). 48.5% of residents had a discrepancy with the potential to result in moderate harm and 9.8% had a discrepancy with the potential for severe harm. Number of medications prescribed was the only factor associated with medication discrepancies.
CONCLUSION
Increased use of systems that allow information sharing and improved interoperability of clinical information is urgently needed to address medication safety issues experienced by RACF residents.

Identifiants

pubmed: 32905865
pii: S1386-5056(20)30071-X
doi: 10.1016/j.ijmedinf.2020.104264
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104264

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Meredith Makeham (M)

The University of Sydney, Faculty of Medicine and Health, Australia; Department of Clinical Medicine, Faculty of Medicine and Health Sciences, Macquarie University, Macquarie Park, NSW, Australia. Electronic address: meredith.makeham@sydney.edu.au.

Lisa Pont (L)

Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Sydney, NSW, Australia; Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Macquarie Park, NSW, Australia.

Carlijn Verdult (C)

Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Sydney, NSW, Australia; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Centre, Leiden, the Netherlands.

Rae-Anne Hardie (RA)

Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Macquarie Park, NSW, Australia.

Magdalena Z Raban (MZ)

Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Macquarie Park, NSW, Australia.

Rebecca Mitchell (R)

Centre for Healthcare Resilience and Implementation Science, Australian Institute of Health Innovation, Macquarie University, Macquarie Park, NSW, Australia.

Helen Purdy (H)

Australian Digital Health Agency, Sydney, NSW, Australia.

Martina Teichert (M)

Department of Clinical Pharmacy & Toxicology, Leiden University Medical Centre, Leiden, the Netherlands.

Andrew Ingersoll (A)

South Western Sydney Local Health District, Liverpool, NSW, Australia.

Johanna I Westbrook (JI)

Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Macquarie Park, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH